ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Ronald M. Becker
Robert W.M. Frater
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Becker, R. M.
Right arrow Articles by Frater, R. W. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Becker, R. M.
Right arrow Articles by Frater, R. W. M.

Ann Thorac Surg 1981;32:120-126
© 1981 The Society of Thoracic Surgeons


Articles

Medium-Term Follow-up of the Ionescu-Shiley Heterograft Valve

Ronald M. Becker, M.D.*, Lawrence Sandor, Michael Tindel, Robert W.M. Frater, M.B., Ch.B.

Department of Surgery, Albert Einstein College of Medicine, Bronx, NY

* Address reprint requests to Dr. Becker, Department of Surgery, Hospital of the Albert Einstein College of Medicine, 1600 Tenbroeck Ave, Bronx, NY 10461

Utilizing a questionnaire specifically designed to uncover potential thromboembolic episodes, we personally interviewed 97 patients who underwent valve replacement with the Ionescu-Shiley valve between January, 1977, and June, 1980. In both the aortic and mitral positions, the attrition rate after the first year was low; cumulative survival at 3 to 4 years was 78% (aortic) and 61% (mitral). None of the deaths were attributed to primary valve failure.

Patients with aortic prostheses, none of whom were anticoagulated, had a cumulative thromboembolism-free rate of 94% at 3 to 4 years. Patients with mitral prostheses had a thromboembolism-free rate of 71% at 3 to 4 years, with 80% of the episodes occurring in patients in atrial fibrillation. Most emboli produced only transient symptoms, and only 1 patient has residual impairment.

The Ionescu-Shiley valve performs well in the early years after valve replacement. Anticoagulation should be strongly considered for patients with mitral prostheses who are in atrial fibrillation.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
L. H. Edmunds Jr.
Thrombotic and Bleeding Complications of Prosthetic Heart Valves
Ann. Thorac. Surg., October 1, 1987; 44(4): 430 - 445.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
G. K. Jett, M. D. Jett, P. Bosco, G. L. van Rijk-Swikker, and R. E. Clark
Left Ventricular Outflow Tract Obstruction Following Mitral Valve Replacement: Effect of Strut Height and Orientation
Ann. Thorac. Surg., September 1, 1986; 42(3): 299 - 303.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. P. Brais, J. P. Bedard, W. Goldstein, A. Koshal, and W. J. Keon
Ionescu-Shiley Pericardial Xenografts: Follow-up of Up to 6 Years
Ann. Thorac. Surg., February 1, 1985; 39(2): 105 - 111.
[Abstract] [PDF]


Home page
JAMAHome page
A. Starr and G. L. Grunkemeier
Selection of a Prosthetic Heart Valve
JAMA, April 6, 1984; 251(13): 1739 - 1742.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
H. Bolooki, S. Mallon, G. A. Kaiser, R. J. Thurer, and J. Kieval
Failure of Hancock Xenograft Valve: Importance of Valve Position (4- to 9-Year Follow-up)
Ann. Thorac. Surg., September 1, 1983; 36(3): 246 - 252.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. W. M. Frater, S. Gabbay, D. Shore, S. Factor, and J. Strom
Reproducible Replacement of Elongated or Ruptured Mitral Valve Chordae
Ann. Thorac. Surg., January 1, 1983; 35(1): 14 - 28.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. Pelletier, B. R. Chaitman, R. Baillot, P. G. Val, R. Bonan, and I. Dyrda
Clinical and Hemodynamic Results with the Carpentier-Edwards Porcine Bioprosthesis
Ann. Thorac. Surg., December 1, 1982; 34(6): 612 - 624.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. I. Ionescu, D. R. Smith, S. S. Hasan, M. Chidambaram, and A. P. Tandon
Clinical Durability of the Pericardial Xenograft Valve: Ten Years' Experience with Mitral Replacement
Ann. Thorac. Surg., September 1, 1982; 34(3): 265 - 277.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
L. H. Edmunds Jr.
Thromboembolic Complications of Current Cardiac Valvular Prostheses
Ann. Thorac. Surg., July 1, 1982; 34(1): 96 - 106.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1981 by The Society of Thoracic Surgeons.